XSTO
NOSA
Market cap12mUSD
Oct 09, Last price
0.46SEK
1D
-0.86%
1Q
-9.98%
Jan 2017
-98.06%
IPO
-97.55%
Name
Frisq Holding AB
Chart & performance
P/E
—
P/S
5.01
EPS
—
Div yield, %
—
Shrs. gr., 5y
49.49%
Rev. gr., 5y
77.24%
Revenues
24m
+48.52%
Net income
-8m
L-20.84%
CFO
-6m
L-36.22%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nosa Plugs AB, a medical technology firm, specializes in developing and marketing intranasal respiratory aids, predominantly across Europe and North America. Their NOSA product portfolio encompasses various solutions: odor control devices for protection against unpleasant smells; microbial control products engineered to diminish the inhalation of viruses and bacteria through the nose; and allergy filters designed to screen out detrimental airborne matter like pollen, pet dander, dust, and mold. The company, established in 2014, is based in Stockholm, Sweden.
Key people
Martin Irding
Chief Executive Officer, Chief Executive Officer of FRISQ AB
Annika Muskantor
Chief Financial Officer · since 2019
Hannes Palm
Head of Business Development, Head of Business Area Private · since 2017
Gustaf Storm
Implementation Manager · since 2018
Casper Winsnes
Interim Product Manager · since 2018
Lars H. Bjork
Director · since 2018
Director · since 2018
Per-Egon Johansson
Director
Ake Hallman
Independent Director
Headquarters & legal address
Surbrunnsgatan 42
Stockholm, AB 113 48
SE
Stockholm, AB 113 48
SE
Previous name
Ecnoyeb AB
Previous name
Goldcup 9444 AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||